BioXcel Therapeutics (BTAI) Asset Utilization Ratio (2022 - 2026)

BioXcel Therapeutics' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.02 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 64.23% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (down 64.23% YoY), while the FY2025 annual figure was 0.02, down 61.87% from the prior year.
• Asset Utilization Ratio was 0.02 for Q1 2026 at BioXcel Therapeutics, up from 0.01 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q4 2024 to a low of 0.0 in Q3 2022.
• Historically, Asset Utilization Ratio has averaged 0.02 across 5 years, with a median of 0.02 in 2026.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 1758.22% in 2023, then plunged 72.45% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2022, then surged by 852.32% to 0.02 in 2023, then jumped by 227.82% to 0.05 in 2024, then slumped by 72.45% to 0.01 in 2025, then climbed by 20.37% to 0.02 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2026), 0.01 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.